Research Article
Research on the Relationship between Government Subsidies and ESG Performance of Medicine Manufacturing Enterprises: Based on the Perspective of Internal Control
@INPROCEEDINGS{10.4108/eai.24-5-2024.2350113, author={Zhuo Sun and Shangjin Li and Mengqiu Wang}, title={Research on the Relationship between Government Subsidies and ESG Performance of Medicine Manufacturing Enterprises: Based on the Perspective of Internal Control}, proceedings={Proceedings of the 3rd International Conference on Mathematical Statistics and Economic Analysis, MSEA 2024, May 24--26, 2024, Jinan, China}, publisher={EAI}, proceedings_a={MSEA}, year={2024}, month={10}, keywords={government subsidies; esg performance; internal control; pharmaceutical manufacturing industry}, doi={10.4108/eai.24-5-2024.2350113} }- Zhuo Sun
Shangjin Li
Mengqiu Wang
Year: 2024
Research on the Relationship between Government Subsidies and ESG Performance of Medicine Manufacturing Enterprises: Based on the Perspective of Internal Control
MSEA
EAI
DOI: 10.4108/eai.24-5-2024.2350113
Abstract
High quality economic development cannot be achieved without the fulfillment of government and corporate responsibilities. ESG is highly in line with global development requirements, and promoting ESG concepts has important strategic significance. Based on this, this article selects pharmaceutical manufacturing listed companies from 2018 to 2022 as the research object, and uses regression analysis methods to explore the impact of government subsidies on the ESG performance of pharmaceutical manufacturing enterprises from the perspective of internal control. government subsidies can improve corporate ESG performance, and internal controls play a partial mediating role. Besides that, government subsidies have a more significant promoting effect on the ESG performance of non-state-owned pharmaceutical manufacturing enterprises.